GL1X · GenesisL1 explorer

MolNFT v1 · #2740 · protein

Structural basis for selectivity of a small molecule, S1-binding, sub- micromolar inhibitor of urokinase type plasminogen activator

1C5Y · Protein (urokinase-type plasminogen activator): “Structural basis for selectivity of a small molecule, S1-binding, sub- micromolar inhibitor of urokinase type…”. X-ray diffraction, 1 ligand (ESP), 1 pocket (best druggability 0.40).…

PDB
1C5Y
Type
protein
Length
257 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Protein (urokinase-type plasminogen activator)
EC
3.4.21.73
UniProt
P00749
Ligands
ESP
Pockets
1 · best druggability 0.40

Structure

x-ray diffraction · 2 distinct chains · 10% helix, 40% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AProtein (urokinase-type plasminogen activator) (EC 3.4.21.73)protein90% helix, 0% strandP00749
BProtein (urokinase-type plasminogen activator) (EC 3.4.21.73)protein24810% helix, 41% strandP00749

Ligands and binding sites

  • ESP · Thieno[2,3-b]pyridine-2-carboxamidine · ligand · chains B
  • FLC · Citrate anion · additive · 3 copies · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11100.400.7626FLC, ESP

Interfaces

1 interface between chains.

  • A–B · 555 Ų buried · 7 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 6 disulfide (disulfide).

Compared structures

  • 1C5Y · Structural basis for selectivity of a small molecule, S1-binding, sub-micromolar… · the same entry in another collection · chain B against B, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.